This clinical trial, sponsored by the University of Colorado, Denver, aims to explore the relationship between sleep health, circadian timing, and cardiometabolic risk in adolescents with Type 1 Diabetes (T1D). Given the rising prevalence of T1D and its associated complications, particularly cardiovascular disease, this study addresses a significant unmet medical need. The potential for non-pharmacological interventions, such as sleep and light therapy, could position this research favorably in the market, especially as current therapies for T1D-related cardiovascular risks are limited. The findings may lead to novel treatment paradigms that could enhance patient outcomes and reduce healthcare costs associated with T1D complications. Stakeholders should monitor the trial's progress for insights into the efficacy of lifestyle interventions in managing T1D-related risks.